Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy

Giovanni Quarta1, Petros Syrris, Michael Ashworth

  • 1The Heart Hospital, University College London Hospitals Trust, 16-18 Westmoreland Street, London W1G 8PH, UK.

European Heart Journal
|December 27, 2011
PubMed

Insights

Mutations in the Lamin A/C gene (LMNA) are linked to severe arrhythmogenic right ventricular cardiomyopathy (ARVC). Genetic testing for LMNA mutations is recommended for ARVC patients, especially those with conduction abnormalities.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart condition primarily linked to desmosomal gene mutations.
  • Lamin A/C gene (LMNA) mutations are known to cause dilated cardiomyopathy, conduction issues, and sudden cardiac death.

Purpose of the Study:

  • To investigate the prevalence of LMNA mutations in a large cohort of ARVC patients.
  • To determine if LMNA mutations are associated with severe ARVC phenotypes.

Main Methods:

  • Genetic screening of 108 ARVC patients for desmosomal genes and LMNA.
  • LMNA mutation analysis using standard PCR and direct sequencing.
  • Histopathological examination of myocardial tissue from affected patients.

Main Results:

  • LMNA mutations were identified in 4% of ARVC patients who did not have desmosomal gene mutations.
  • Patients with LMNA mutations exhibited severe right ventricular involvement, conduction abnormalities, and increased mortality.
  • Myocardial analysis revealed myocyte loss and fibro-fatty replacement, with reduced plakoglobin staining at intercalated discs.

Conclusions:

  • LMNA gene mutations are associated with severe forms of ARVC.
  • Genetic testing for LMNA should be included in the workup for suspected ARVC, particularly in patients with ECG-detected conduction disease.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...